Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
48.31
-1.54 (-3.09%)
Jun 5, 2025, 4:00 PM - Market closed
Bio-Techne Stock Forecast
Stock Price Forecast
According to 10 professional analysts, the 12-month price target for Bio-Techne stock ranges from a low of $59 to a high of $90. The average analyst price target of $72 forecasts a 49.04% increase in the stock price over the next year.
Price Target: $72.00 (+49.04%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Bio-Techne stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 2 | 3 | 3 | 4 | 4 |
| Hold | 3 | 3 | 3 | 4 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 7 | 8 | 9 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +55.25% | Jun 5, 2025 |
| Wells Fargo | Wells Fargo | Buy Initiates $59 | Buy | Initiates | $59 | +22.13% | May 30, 2025 |
| UBS | UBS | Strong Buy Maintains $95 → $70 | Strong Buy | Maintains | $95 → $70 | +44.90% | May 9, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $72 → $63 | Hold | Maintains | $72 → $63 | +30.41% | May 8, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $95 → $75 | Strong Buy | Maintains | $95 → $75 | +55.25% | May 8, 2025 |
Financial Forecast
Revenue This Year
1.24B
from 1.16B
Increased by 7.07%
Revenue Next Year
1.31B
from 1.24B
Increased by 5.88%
EPS This Year
1.96
from 1.05
Increased by 86.28%
EPS Next Year
2.14
from 1.96
Increased by 9.30%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.3B | 1.4B | 1.5B | |||
| Avg | 1.2B | 1.3B | 1.4B | |||
| Low | 1.2B | 1.2B | 1.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 10.6% | 11.9% | 15.0% | |||
| Avg | 7.1% | 5.9% | 9.0% | |||
| Low | 2.4% | 0.3% | 1.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.17 | 2.31 | 2.71 | ||
| Avg | 1.96 | 2.14 | 2.45 | ||
| Low | 1.84 | 1.94 | 2.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 107.0% | 18.1% | 26.7% | ||
| Avg | 86.3% | 9.3% | 14.6% | ||
| Low | 75.5% | -0.8% | 2.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.